The Stark Reality of Outdated Kidney Care
Imagine receiving a diagnosis of a life-threatening illness—only to discover that your physician is restricted to treatments and medical tools from the early 2000s, despite the existence of…
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Julio Martinez-Clark, CEO at Bioaccess, a CRO that specializes in executing first-in-human…
Continue Reading
Justin Kozak, Executive VP at Founder Shield
Digital therapeutics (DTx) are revolutionizing healthcare — from smart inhalers to virtual therapy avatars. As more patients turn to DTx apps, companies rush to deliver innovative features. But in the race to…
Continue Reading
Revolutionary FDA Approval Marks Medical Milestone
Startup Clairity has achieved a groundbreaking milestone in healthcare technology, securing FDA approval for the agency’s first artificial intelligence tool specifically designed to predict five-year breast cancer risk from…
Major FDA Milestone for Pediatric Care
The U.S. Food and Drug Administration has granted pediatric approval for GE HealthCare’s Optison, marking a significant advancement in pediatric cardiac imaging. This ultrasound enhancing agent will now help…
Promise and Paradox in Cell Therapy Growth
Cell and gene therapies (CGTs) stand at the precipice of transformative growth, with Cardinal Health’s “2025 Advanced Therapies Report” projecting over 200 FDA-approved treatments and 100,000+ U.S. patients…
Bipartisan Legislation Targets Healthcare Innovation
Groundbreaking bipartisan legislation has been reintroduced by Senators Capito and Shaheen that could transform Medicare’s approach to digital therapeutics. The Access to Prescription Digital Therapeutics Act of 2023 aims to…
Healthcare Organizations Embrace AI at Unprecedented Rates
Healthcare is experiencing a dramatic shift toward artificial intelligence, with 70% of healthcare payers and providers now actively implementing generative AI technologies. This represents a significant move beyond…
Guidelines and guardrails for the safe use of AI require more than regulation. The Coalition for Health AI has created a framework to reduce these risks and improve the safety and effectiveness of these…
Continue Reading
BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
